# Metronomic Treatment in Children and Adolescents With Recurrent or Progressive High Risk Neuroblastoma

> **NCT02641314** · PHASE2 · COMPLETED · sponsor: **University of Cologne** · enrollment: 18 (actual)

## Conditions studied

- Recurrent Neuroblastoma

## Interventions

- **DRUG:** metronomic therapy

## Key facts

- **NCT ID:** NCT02641314
- **Lead sponsor:** University of Cologne
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12-22
- **Primary completion:** 2023-06-29
- **Final completion:** 2023-06-29
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2024-05-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02641314

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02641314, "Metronomic Treatment in Children and Adolescents With Recurrent or Progressive High Risk Neuroblastoma". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT02641314. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*